A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma

Clinical trial NCT05095441 · UNKNOWN

Trial details

NCT number: NCT05095441
Sponsor: ImmVira Pharma Co. Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Glioblastoma Glioblastoma Multiforme Glioblastoma Multiforme of Brain

Start date: 2023-03-15
Primary completion: 2023-04-30
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.